WinstonWınston
Back
Precision BioSciences logo

Precision BioSciences

DTIL
Biotechnology · Healthcare
Exchange
NASDAQ
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Winston Score History

The full picture

Precision BioSciences is a small biotech company that uses a gene-editing tool it invented, called ARCUS, to change or fix DNA inside living cells. Its main focus is on making cancer treatments — specifically a type of therapy where edited immune cells are used to attack tumors — as well as working on treatments for genetic diseases. The company sells research licenses to other biotech and pharmaceutical companies that want to use its ARCUS technology.

Precision BioSciences earns money through licensing deals, research collaborations, and milestone payments from partners, which explains its high gross margin despite losing money overall. It operates primarily in the United States and is a very small company with a market cap around $100 million. The ARCUS gene-editing platform is its core competitive asset, but the company faces significant risk from cash burn and competition from larger gene-editing players like CRISPR Therapeutics and Beam Therapeutics, making its path to profitability uncertain.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+40.8% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

23.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~20 months

$88M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Adequate runway but may need to raise capital within 2 years

Revenue declining

Precision BioSciences's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
-36.7%
Weak — -36.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
>+1,000%
Fast-growing sales (>+1,000% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-115.3%
Burning cash (-115.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.04
Conservative — low debt load (0.04)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial